Dark

Check out our Dark Pool Levels

ELOX
ELOXX PHARMACEUTICALS INC
stock OTC

EOD

Feb 24, 2026

0.000100USD0.000%(0.000000)238

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Dec 20, 2021

07:25AM EST The following are some of the stocks making big moves in Monday's pre-market trading (as of 07.10 A.M. ET). RTTNews

Dec 17, 2021

10:18AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021 Benzinga

05:46AM EST Oppenheimer Initiates Coverage On Eloxx Pharmaceuticals with Outperform Rating, Announces Price Target of $4 Benzinga

Nov 18, 2021

07:18AM EST 10 Biggest Price Target Changes For Thursday Benzinga

06:17AM EST HC Wainwright & Co. Maintains Neutral on Eloxx Pharmaceuticals, Lowers Price Target to $1 Benzinga

Nov 17, 2021

07:27AM EST Eloxx Pharma Reports Positive Topline Results From Monotherapy Arms Of Phase 2 Trial Of ELX-02 In Class 1 CF RTTNews

07:07AM EST Eloxx Pharmaceuticals Reports Topline Results From Monotherapy Arms of Phase 2 Clinical Trial Of ELX-02 In Class 1 Cystic Fibrosis Patients; Study Met Key Primary Endpoint Benzinga

07:00AM EST ELX-02 monotherapy dosed at 1.5mg/kg/day demonstrated a statistically significant 5.4mmol/L mean sweat chloride reduction, an established surrogate for restoration of CFTR biological activity GlobeNewswire Inc

Nov 11, 2021

06:40AM EST HC Wainwright & Co. Maintains Neutral on Eloxx Pharmaceuticals, Lowers Price Target to $2 Benzinga

Nov 9, 2021

11:45AM EST Eloxx Pharmaceuticals Q3 EPS $(0.11) Up From $(0.16) YoY Benzinga

08:00AM EST Data from Monotherapy Arms of Ongoing Phase 2 ELX-02 Cystic Fibrosis (CF) Clinical Trials Expected in Fourth Quarter of 2021 GlobeNewswire Inc

Oct 7, 2021

04:15PM EDT Globally renowned CF Expert, Dr. Eitan Kerem will provide key insights GlobeNewswire Inc

Oct 5, 2021

10:58AM EDT Eloxx Pharma US Patent & Trademark Office Abstract For Co.'s 'Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereof' Benzinga

08:08AM EDT Eloxx Pharmaceuticals Secures Debt Facility Of Up To $30M From Hercules Capital Benzinga

08:00AM EDT Eloxx Pharmaceuticals Secures Debt Facility of Up to $30 Million GlobeNewswire Inc

Sep 30, 2021

08:56AM EDT Eloxx Pharmaceuticals Enters Sales Agreement With SVB Leerink Pursuant To Which Co. May Offer And Sell Up To $50M Of Common Stock Through At The Market Offering Benzinga

Sep 9, 2021

08:01AM EDT Eloxx Pharmaceuticals Shares Spike Higher; Co Announces Fast Track Designation For ELX-02 For Treatment Of Cystic Fibrosis Patients With Nonsense Mutations Benzinga

08:00AM EDT Eloxx Pharmaceuticals Announces Fast Track Designation for ELX-02 GlobeNewswire Inc

Sep 8, 2021

08:04AM EDT Eloxx Pharmaceuticals Appoints Ali Hariri, M.D. As Chief Medical Officer Benzinga

08:00AM EDT Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), today announced the appointment of Ali Hariri, M.D., as its Chief Medical Officer, overseeing clinical development efforts for the companys promising pipeline of therapies to treat rare diseases. Dr. Hariri will report to Vijay Modur, M.B.B.S., Ph.D., the companys Head of Research and Development. GlobeNewswire Inc

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Aug 16, 2021

04:32PM EDT Eloxx Pharmaceuticals Q2 EPS $(0.54) Down From $(0.20) YoY Benzinga

04:05PM EDT Added Additional Treatment Arm and Provided Enrollment Update for Ongoing ELX-02 Phase 2 Clinical Trials for Cystic Fibrosis (CF) GlobeNewswire Inc

Jul 20, 2021

08:20AM EDT The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street Benzinga

Jul 7, 2021

08:04AM EDT Eloxx Pharma Sees Data Readout From First Four Arms Of Cystic Fibrosis Study By End Of 2021 Benzinga

Jul 6, 2021

04:16PM EDT Eloxx Pharmaceuticals Provides Enrollment Update for Ongoing Phase 2 Clinical Studies for Cystic Fibrosis Benzinga

04:15PM EDT Eloxx Pharmaceuticals Provides Enrollment Update for Ongoing Phase GlobeNewswire Inc

Jun 30, 2021

10:56AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2021 Benzinga

05:05AM EDT Mizuho Initiates Coverage On Eloxx Pharmaceuticals with Buy Rating, Announces Price Target of $3.1 Benzinga

Jun 16, 2021

05:02AM EDT 44 Biggest Movers From Yesterday Benzinga

Jun 15, 2021

08:07AM EDT The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda Benzinga

May 27, 2021

10:02AM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2021 Benzinga

08:37AM EDT Eloxx Pharmaceuticals Receives Up To $2.6M Benzinga

08:30AM EDT Leverages TURBO-ZMSynthetic Chemistry Platform for Designing Oral Macrolide-based Ribosome Modulating Agents (RMAs) GlobeNewswire Inc

06:22AM EDT B. Riley Securities Initiates Coverage On Eloxx Pharmaceuticals with Buy Rating, Announces Price Target of $5 Benzinga

May 18, 2021

02:15PM EDT Eloxx Pharmaceuticals, Inc. Announces Closing of Public Offering GlobeNewswire Inc

May 14, 2021

07:59AM EDT The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts Benzinga

07:01AM EDT Eloxx Pharma Prices 33.33M Shares At $1.35/Share Benzinga

07:00AM EDT Eloxx Pharmaceuticals, Inc. Announces Pricing of Public Offering GlobeNewswire Inc

May 13, 2021

04:42PM EDT Eloxx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock; No Terms Disclosed Benzinga

04:01PM EDT Eloxx Pharmaceuticals, Inc. Announces Proposed Public Offering of GlobeNewswire Inc

08:10AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use Benzinga

May 7, 2021

07:40AM EDT The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs Benzinga

May 6, 2021

05:54PM EDT Eloxx Pharmaceuticals Q1 EPS $(0.22) Up From $(0.35) YoY Benzinga

Apr 30, 2021

07:31AM EDT The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs Benzinga

Apr 29, 2021

04:56PM EDT Eloxx Pharma Reports Added Treatment Arm To Ongoing Phase 2 Clinical Studies For Cystic Fibrosis Benzinga

04:54PM EDT Eloxx Pharmaceuticals Adds Additional Treatment Arm To Ongoing Phase 2 Clinical Studies For Cystic Fibrosis Benzinga

Apr 13, 2021

02:08PM EDT Advent Life Sciences Discloses 6.3% Active Stake In Eloxx Pharmaceuticals Benzinga

Apr 1, 2021

12:25PM EDT Eloxx Pharmaceuticals shares are trading higher after the company announced it acquired Zikani Therapeutics. Benzinga

09:37AM EDT Eloxx Stock is Trading Higher After Zikani Therapeutics Acquisition Benzinga

08:20AM EDT Eloxx Pharmaceuticals, Inc. (ELOX) has acquired Zikani Therapeutics, Inc. in an all-stock deal. Stockholders of Zikani received approximately 7.6 million Eloxx common shares and own approximately 16 percent of the combined company. RTTNews

07:53AM EDT Eloxx Pharmaceuticals Buys Zikani Therapeutics RTTNews

07:46AM EDT Eloxx Pharmaceuticals Acquires Zikani Therapeutics; Zikani Stockholders To Receive 7.6M Eloxx Shares Benzinga

07:45AM EDT Combined Company to be Leader in Ribosomal RNA-Targeted Genetic Therapy Bringing Together Complementary Platforms GlobeNewswire Inc

Mar 11, 2021

04:03PM EST Eloxx Pharmaceuticals Q4 EPS $(0.15) Beats $(0.21) Estimate Benzinga

04:01PM EST We expect to report top line data from our Phase 2 cystic fibrosis clinical trials in the first half of this year GlobeNewswire Inc

08:19AM EST The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena Benzinga

03:35AM EST Earnings Scheduled For March 11, 2021 Benzinga

Mar 4, 2021

05:15PM EST Eloxx Pharmaceuticals to Report Fourth Quarter and Full Year 2020 GlobeNewswire Inc

Feb 9, 2021

07:04AM EST Eloxx Highlights Publication Of Scientific Manuscript On ELX-02 In The Journal Of Cystic Fibrosis Benzinga

07:00AM EST Eloxx Announces Publication of Scientific Manuscript on ELX-02 in GlobeNewswire Inc

Jan 26, 2021

07:09AM EST Eloxx Pharma Highlights Publication Of Scientific Manuscript On ELX-02 In Journal Of Clinical Pharmacology In Drug Development Benzinga

07:00AM EST Publication titled: A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX-02 in Healthy Subjects GlobeNewswire Inc

Jan 20, 2021

07:05AM EST Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Clinical Pharmacology Benzinga

07:00AM EST Eloxx Announces Publication of Scientific Manuscript on ELX-02 in GlobeNewswire Inc

Jan 13, 2021

09:02AM EST Eloxx Pharmaceuticals Announces Cystic Fibrosis Foundation (CF Foundation) To Provide Increased Funding And Support For ELX-02 Global Phase 2 Clinical Trial Program Benzinga

09:00AM EST The CF Foundations partial funding of the U.S. trial has been extended to partial funding of the global clinical trial program which includes Europe and Israel GlobeNewswire Inc

Nov 18, 2020

11:30AM EST Eloxx Pharmaceuticals to Present at the Piper Sandler 32nd Annual GlobeNewswire Inc

Nov 9, 2020

08:00AM EST Global Health Sciences Fund (Quark Venture LP and GF Securities) GlobeNewswire Inc

Nov 5, 2020

04:35PM EST Eloxx Pharmaceuticals Q3 EPS $(0.16) Beats $(0.19) Estimate Benzinga

07:54AM EST The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping Benzinga

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Nov 1, 2020

09:40AM EST The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings Benzinga

Oct 27, 2020

07:50AM EDT Eloxx Announces The Publication Of Two Manuscripts On ELX-02 And Its ERSG Library In Two Leading Journals Benzinga

07:30AM EDT A Publication titled: ELX-02: an investigational read-through agent for the treatment of nonsense mutation-related genetic disease has been published in the Expert Opinion on Investigational Drugs Journal GlobeNewswire Inc

Oct 22, 2020

08:58AM EDT Eloxx Presents Two Preclinical Posters at the 2020 North American GlobeNewswire Inc

Oct 15, 2020

07:00AM EDT Eloxx Pharmaceuticals to Report Third Quarter 2020 Financial GlobeNewswire Inc

Sep 14, 2020

10:06AM EDT Globally Renowned Cystic Fibrosis Expert, Dr. Eitan Kerem, Joins GlobeNewswire Inc

Aug 26, 2020

07:34AM EDT Eloxx Announces Two Preclinical Abstracts Accepted For Presentation At 2020 North American Cystic Fibrosis Virtual Conference In Oct. Benzinga

07:30AM EDT Eloxx Announces Two Preclinical Abstracts Accepted for GlobeNewswire Inc

Aug 12, 2020

07:36AM EDT Eloxx Resumes Enrollment In U.S. Phase 2 Clinical Trial In Cystic Fibrosis RTTNews

07:32AM EDT Eloxx Pharmaceuticals Announces Enrollment In US Phase 2 Clinical Trial In Cystic Fibrosis Has Resumed After Being Paused In Response To COVID-19 Pandemic Benzinga

07:30AM EDT Enrollment in the U.S. Phase 2 Clinical Trial in Cystic Fibrosis GlobeNewswire Inc

Aug 6, 2020

08:21AM EDT Eloxx Pharmaceuticals Q2 EPS $(0.20) Beats $(0.21) Estimate Benzinga

07:57AM EDT The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO Benzinga

07:30AM EDT Enrollment in our Phase 2 clinical trial program for ELX-02 in cystic fibrosis has been resumed in Europe and Israel after being temporarily paused due to the COVID-19 pandemic GlobeNewswire Inc

Aug 4, 2020

07:51AM EDT Eloxx Pharmaceuticals Receives US Orphan Drug Designation For ELX-02 For The Treatment Of Cystic Fibrosis Benzinga

07:30AM EDT Eloxx Pharmaceuticals Receives U.S. Orphan Drug Designation for GlobeNewswire Inc

Jul 28, 2020

12:34PM EDT Eloxx Pharmaceuticals to Present at the 40th Annual Canaccord GlobeNewswire Inc

Jul 21, 2020

02:17PM EDT Eloxx Pharmaceuticals to Report Second Quarter 2020 Financial GlobeNewswire Inc

Jul 15, 2020

01:11PM EDT Eloxx Announces Publication Of Scientific Manuscript On ELX-02 Benzinga

Share